BR0109893A - Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente - Google Patents

Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente

Info

Publication number
BR0109893A
BR0109893A BR0109893-4A BR0109893A BR0109893A BR 0109893 A BR0109893 A BR 0109893A BR 0109893 A BR0109893 A BR 0109893A BR 0109893 A BR0109893 A BR 0109893A
Authority
BR
Brazil
Prior art keywords
lerisetron
active substance
preparation
therapeutic system
patient
Prior art date
Application number
BR0109893-4A
Other languages
English (en)
Inventor
Torsten Selzer
Petra Botzem
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BR0109893A publication Critical patent/BR0109893A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PREPARAçãO FARMACêUTICA DE LERISETRON NA FORMA DE UM SISTEMA TERAPêUTICO TRANSDéRMICO, USO DA PREPARAçãO, USO DA SUBSTâNCIA ATIVA LERISETRON E MéTODO PARA ADMINISTRAR A SUBSTâNCIA ATIVA LERISETRON A UM PACIENTE". A presente invenção trata de uma preparação farmacêutica na forma de um sistema terapêutico transdérmico (TTS) que compreende uma camada de apoio, conectada à mesma pelo menos um adesivo sensível a pressão de camada única, o reservatório de substância ativa de lerisetron com base em adesivo(s) sensível(veis) a pressão de silicone, e uma camada protetora removível.
BR0109893-4A 2000-03-30 2001-03-17 Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente BR0109893A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10015783A DE10015783C2 (de) 2000-03-30 2000-03-30 Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung
PCT/EP2001/003089 WO2001074338A1 (de) 2000-03-30 2001-03-17 Transdermales therapeutisches system zur abgabe von lerisetron

Publications (1)

Publication Number Publication Date
BR0109893A true BR0109893A (pt) 2003-04-01

Family

ID=7636948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109893-4A BR0109893A (pt) 2000-03-30 2001-03-17 Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente

Country Status (16)

Country Link
US (1) US20040001881A1 (pt)
EP (1) EP1267846B1 (pt)
JP (1) JP2003528912A (pt)
KR (1) KR100624500B1 (pt)
AR (1) AR028525A1 (pt)
AT (1) ATE310510T1 (pt)
AU (1) AU782487B2 (pt)
BR (1) BR0109893A (pt)
CA (1) CA2403949C (pt)
DE (2) DE10015783C2 (pt)
ES (1) ES2254425T3 (pt)
HU (1) HUP0204448A3 (pt)
IL (2) IL151922A0 (pt)
MX (1) MXPA02009103A (pt)
NZ (1) NZ521099A (pt)
WO (1) WO2001074338A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
WO2003100091A1 (en) * 2002-05-24 2003-12-04 Epidauros Biotechnologie Ag Means and methods for improved treatment using 'setrones'
GB0302662D0 (en) 2003-02-05 2003-03-12 Strakan Ltd Transdermal granisetron
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
WO2006028863A1 (en) * 2004-09-01 2006-03-16 Nexmed Holdings, Inc. Transdermal antiemesis delivery system, method and composition therefor
DE102004044578A1 (de) * 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
PL2450041T3 (pl) 2005-10-12 2019-02-28 Unimed Pharmaceuticals, Llc Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu
CN101909651B (zh) * 2007-11-22 2013-11-06 美德阿利克斯株式会社 包括基于脂肪酸的离子型液体作为活性成分的外用制剂组合物
FR2943253B1 (fr) * 2009-03-20 2011-04-22 Oreal Composition contenant l'association de madecassoside, d'une arginine et de polysorbate
JP5681883B2 (ja) * 2009-03-27 2015-03-11 株式会社 メドレックス 核酸を有効成分とする外用剤組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
US5256665A (en) * 1991-05-10 1993-10-26 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. Process for preparing new 2-piperazinylbenzimidazole
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JPH10167956A (ja) * 1996-12-11 1998-06-23 Hisamitsu Pharmaceut Co Inc セロトニン受容体拮抗薬含有経皮投与製剤
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US6136807A (en) * 1998-11-10 2000-10-24 3M Innovative Properties Company Composition for the transdermal delivery of lerisetron

Also Published As

Publication number Publication date
AU6210701A (en) 2001-10-15
US20040001881A1 (en) 2004-01-01
HUP0204448A2 (en) 2003-05-28
EP1267846A1 (de) 2003-01-02
DE50108168D1 (de) 2005-12-29
ES2254425T3 (es) 2006-06-16
JP2003528912A (ja) 2003-09-30
AU782487B2 (en) 2005-08-04
HUP0204448A3 (en) 2004-07-28
CA2403949C (en) 2008-09-16
NZ521099A (en) 2006-11-30
ATE310510T1 (de) 2005-12-15
IL151922A0 (en) 2003-04-10
DE10015783A1 (de) 2001-10-11
KR100624500B1 (ko) 2006-09-18
KR20020084161A (ko) 2002-11-04
CA2403949A1 (en) 2002-09-26
IL151922A (en) 2007-10-31
WO2001074338A1 (de) 2001-10-11
EP1267846B1 (de) 2005-11-23
MXPA02009103A (es) 2004-08-12
AR028525A1 (es) 2003-05-14
DE10015783C2 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
NO952907D0 (no) Transdermalt terapeutisk system med galanthamin som virksom bestanddel
BRPI0517501A (pt) dispositivo médico apropriado para uso na administração de um componente ativo na ou através da pele
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
BR9712806A (pt) Emplastro de matriz adesiva sensìvel à pressão para liberação transdérmica de sais de agentes farmacêuticos
DK193389D0 (da) Transdermalt farmaceutisk system
AR025426A1 (es) Sales farmaceuticas de la sustancia activa tramadol y al menos un edulcorante, medicamentos que contienen estas sales, el uso de estas sales para lapreparacion de medicamentos y formas de administracion que contienen esas sales
DK1009393T3 (da) Transdermalt, terapeutisk system med hæfteklæbende reservoirlag og bagsidelag, som er elastisk i én retning
MX9307885A (es) Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos.
PT1256339E (pt) Sistema terapeutico transdermico para doenca de parkinson que induz niveis plasmaticos altos de rotigotina
AR020803A1 (es) Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento
BRPI0411032A (pt) composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica
ES2118249T3 (es) Parche que contiene dexpanthenol para la aplicacion percutanea de hormonas esteroideas.
NO952908L (no) Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret
BR0011135A (pt) Sistema de ministração terapêutica transdérmica, processo para ministrar um neuroléptico altamente potente a um indivìduo,e uso de um sistema de ministração terapêutica transdérmica
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu
ES2178798T3 (es) Medicamento nefroprotector.
AR017198A1 (es) Proceso para la preparacion de isopropil-metil-[2-(3-n-propoxifenoxi)etil]amina, formulaciones farmaceuticas de la misma e intermediarios para uso endicho proceso.
PT944384E (pt) Sistema para administracao transdermica de farmacos para o tratamento de doencas do coracao
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
BR0312333A (pt) Terapia de combinação e agente para sua execução

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.